Clinical Trial Update: Combination Therapy With VRC01 and 10-1074 in HIV-Infected Individuals Undergoing Sequential Treatment Interruptions [Phase 1]

View source ↗

Summary

Phase 1 trial investigating combination therapy with VRC01 and 10-1074 in HIV-infected individuals undergoing sequential treatment interruptions; study is termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 10-1074
• VRC01 (VRC01)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: TERMINATED | Results posted: 2021-10-12